The Aetion Coalition to Advance Real‐World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology-Reference-Cited by-同舟云学术

The Aetion Coalition to Advance Real‐World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology

Published:2022-12-07 Issue: Volume: Page:
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Merola David¹^ORCID,Campbell Ulka¹,Gautam Nileesa¹,Rubens Alexa¹,Schneeweiss Sebastian²^ORCID,Wang Shirley V.²^ORCID,Carrigan Gillis³^ORCID,Chia Victoria³,Ovbiosa Osayi E.⁴^ORCID,Pinheiro Simone⁴,Bruno Amanda⁵,Jiao Xiaolong⁵,Stewart Mark⁶^ORCID,Hendricks‐Sturrup Rachele⁷,Rodriguez‐Watson Carla⁸,Khosla Sajan⁹,Zhang Yiduo⁹,Rimawi Mothaffar¹⁰,Huang Jenny¹¹,Taylor Aliki¹¹,Becnel Lauren¹²,McRoy Lynn¹²,Eckert Joy⁸,Taylor Benjamin¹

Affiliation:

1. Aetion, Inc. New York New York USA

2. Division of Pharmacoepidemiology and Pharmacoeconomics Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

3. Center for Observational Research Amgen San Francisco California USA

4. AbbVie North Chicago Illinois USA

5. Bayer Pharmaceuticals Philadelphia Pennsylvania USA

6. Friends of Cancer Research Washington District of Columbia USA

7. Duke‐Margolis Center for Health Policy Washington District of Columbia USA

8. Reagan‐Udall Foundation for the Food and Drug Administration Washington District of Columbia USA

9. AstraZeneca Gaithersburg Maryland USA

10. Baylor College of Medicine Houston Texas USA

11. Gilead Sciences Foster City California USA